Michael Chi - 10 Jun 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Commercial Officer
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
10 Jun 2025
Net transactions value
-$282,372
Form type
4
Filing time
11 Jun 2025, 20:09:27 UTC
Previous filing
09 Jun 2025
Next filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chi Michael Chief Commercial Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 11 Jun 2025 0001965903
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $36,828 +5,400 +2.1% $6.82 261,980 10 Jun 2025 Direct F1
transaction HIMS Class A Common Stock Sale $319,200 -5,600 -2.1% $57.00 256,380 10 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -5,400 -4.1% $0.000000 125,262 10 Jun 2025 Class A Common Stock 5,400 $6.82 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.
F2 The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.